Together we will beat cancerDonate
The National Institute for Health and Care Excellence (NICE) has recommended zanubrutinib (Brukinsa) as an option for treating some people…
A targeted cancer drug has been approved to treat some people with breast cancer that has a high-risk of returning.
Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England
Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.
A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.
Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.
A British woman with an incurable cancer has broken the world record for rowing across the Atlantic, raising thousands for Cancer Research UK.
Pixie Lott and other celebrity guests surprise children with messages of support in virtual Star Award ceremony, celebrates the courage of children with cancer.
Three new treatment options made available for cancer patients in Scotland.
Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.